EUDA Health (EUDA) to Announce Quarterly Earnings on Tuesday

EUDA Health (NASDAQ:EUDA) is expected to be issuing its results before the market opens on Tuesday, July 28th. Analysts expect the company to post earnings of $0.40 per share and revenue of $9.6090 million for the quarter.

EUDA Health (NASDAQ:EUDA) last issued its earnings results on Tuesday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.76. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million.

EUDA Health Trading Up 7.1%

Shares of NASDAQ:EUDA opened at $14.99 on Friday. The company has a 50-day simple moving average of $15.01 and a 200 day simple moving average of $17.06. EUDA Health has a 52-week low of $5.26 and a 52-week high of $86.00.

Institutional Trading of EUDA Health

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC raised its position in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,631 shares of the company’s stock after buying an additional 16,321 shares during the quarter. Citadel Advisors LLC owned 0.12% of EUDA Health worth $78,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 4.35% of the company’s stock.

Analyst Ratings Changes

EUDA has been the subject of several research analyst reports. Weiss Ratings downgraded EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. Zacks Research upgraded EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, EUDA Health has an average rating of “Hold” and a consensus target price of $55.00.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.